Success Story: I-140 NIW Approval for a Vascular Biology Researcher Advancing Therapeutic Strategies for Vascular Disease
Client’s Testimonial:
"I truly appreciate your help and support throughout the process.”
On May 1st, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Scholar in the Field of Vascular Biology (Approval Notice).
General Field: Vascular Biology
Position at the Time of Case Filing: Postdoctoral Scholar
Country of Origin: South Korea
State of Residence at the Time of Filing: California
Approval Notice Date: May 1st, 2026
Processing Time: 12 months, 28 days (Premium Processing Upgrade Requested)
Case Summary:
We are pleased to share that the client’s I-140 NIW petition was approved. The client is an expert in vascular biology whose proposed endeavor focuses on developing cell culture and animal models to identify therapeutic targets or treatments that may slow the progression of vascular diseases, including hypertension and atherosclerosis. The client is currently conducting research in the United States and plans to continue advancing work related to endothelial cell biology, vascular inflammation, and disease progression.
The petition presented the client’s work as important not simply because it concerns cardiovascular disease, but because it addresses the biological mechanisms that may guide more effective therapies. By studying how endothelial cells respond to blood-flow conditions and how cellular changes contribute to inflammation, the client’s research supports a clearer understanding of vascular disease development and potential treatment strategies.
To demonstrate that the client was well-positioned to advance this work, the petition highlighted 9 peer-reviewed journal articles, including 7 first- or co-first-authored articles, 8 conference abstracts, including 3 first-authored abstracts, and 4 preprints, including 2 first-authored preprints.
The petition also explained the client’s 234 citations in context. Rather than treating the citation count as sufficient on its own, the case showed that other researchers had relied on the client’s findings in studies involving endothelial cell dynamics, inflammation, mitochondrial remodeling, and vascular physiology. Several publications also ranked highly by citation percentile for their respective years, helping an adjudicator evaluate the influence of the work against appropriate field and time-based benchmarks.
The case emphasized three main points. First, the client’s publication record showed sustained productivity in vascular biology. Second, the citation record showed that the work had been used by other researchers, reflecting independent reliance. Third, the client’s specialized expertise in live-cell imaging, endothelial cell biology, and disease modeling supported the argument that he is well-positioned to continue advancing research with public health relevance.
This I-140 NIW approval recognizes the client’s advanced training, focused vascular biology research, publication record, citation impact, and continuing plans to study therapeutic targets for vascular disease. We congratulated the client on this important approval.